Zynerba Pharmaceuticals (ZYNE)

[Fress]

this has good data, its a 700M dollar stock. Why not buy now when it's a 280 million dollar stock? This gets approved and does 10+ million in it's first q on market, and this is a 1.5B dollar stock. After a full year on market where it does nearly 100m, this is a 4 billion dollar stock, so why not buy at 280 million..

80% of fast tracked drugs in the last 2 years have gotten approved.

Thats what the smart money is doing we also have a big update between now and the end of the month.


$ZYNE.